Featured Research

from universities, journals, and other organizations

Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes

Date:
June 12, 2009
Source:
American Academy of Sleep Medicine
Summary:
Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to new research.

Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to a research abstract that will be presented on June 9, at Sleep 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

Results indicate that compared with people who slept six hours or more while being monitored in the sleep laboratory, individuals with insomnia who slept for five or fewer hours had the highest risk of diabetes (odds ratio of 2.95); people with insomnia who slept for five to six hours also had an elevated risk of diabetes (odds ratio of 2.07).

The study gathered data from 1,741 men and women who were randomly selected from Central Pennsylvania; participants were studied in a sleep laboratory. Diabetes was defined based on either fasting blood sugar or treatment. Insomnia was defined by a complaint of insomnia with a duration of at least one year, while "poor sleep" was defined as a complaint of difficulty falling asleep, staying asleep or early final awakening. Polysomnographic sleep duration was classified into three categories: people who slept for six or more hours, those who slept five to six hours and those who slept for five hours or less. Logistic regression was used to calculate odds ratios for diabetes.

According to lead author Alexandros Vgontzas, MD, endowed chair in Sleep Disorders Medicine at Penn State College of Medicine in Hershey, Pa., patients suffering from insomnia with short sleep duration are at a serious health risk.

"The more severe form of insomnia (insomnia with short objective sleep duration) is associated with a risk for diabetes that is similar to the elevated risk associated with obstructive sleep apnea," said Vgontzas.

Other studies also have found serious medical risks associated with insomnia and objective short sleep duration; another study led by Vgontzas that will be presented at SLEEP 2009 found that insomnia with objective short sleep duration is also associated with increased risk of mortality in men.

According to the study's authors, findings indicate that people with insomnia should seek evaluation and treatment from their medical provider. Although the results suggest that people with insomnia have a lower risk for physical problems if their sleep duration is normal, they still are at risk for depression and may suffer from the behavioral effects of insomnia.

Abstract Title: Insomnia with Objective Short Sleep Duration is Associated with Diabetes


Story Source:

The above story is based on materials provided by American Academy of Sleep Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Sleep Medicine. "Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes." ScienceDaily. ScienceDaily, 12 June 2009. <www.sciencedaily.com/releases/2009/06/090609072715.htm>.
American Academy of Sleep Medicine. (2009, June 12). Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/06/090609072715.htm
American Academy of Sleep Medicine. "Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes." ScienceDaily. www.sciencedaily.com/releases/2009/06/090609072715.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins